Approval · Notice of Compliance 37037 · 2026
QULIPTA: Notice of Compliance 37037
Issued March 4, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37037
- Date
- March 4, 2026
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product (Addition of an alternate analytical method for Content Uniformity test by Transmission Raman spectroscopy in the drug product specification)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QULIPTA | Not yet assigned | — |